WAS
Wealth Advisory Solutions’s Citius Pharmaceuticals CTXR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-201,000
| Closed | -$101K | – | 129 |
|
|
2024
Q3 | $101K | Buy |
201,000
+50,000
| +33% | +$25K | 0.03% | 122 |
|
|
2024
Q2 | $88.1K | Hold |
151,000
| – | – | 0.02% | 123 |
|
|
2024
Q1 | $135K | Buy |
+151,000
| New | +$135K | 0.04% | 123 |
|
|
2023
Q4 | – | Sell |
-154,130
| Closed | -$105K | – | 83 |
|
|
2023
Q3 | $105K | Buy |
+154,130
| New | +$105K | 0.02% | 115 |
|
|
2023
Q2 | – | Sell |
-155,850
| Closed | -$182K | – | 100 |
|
|
2023
Q1 | $182K | Hold |
155,850
| – | – | 0.05% | 126 |
|
|
2022
Q4 | $123K | Sell |
155,850
-1,000
| -0.6% | -$790 | 0.03% | 129 |
|
|
2022
Q3 | $190K | Hold |
156,850
| – | – | 0.05% | 129 |
|
|
2022
Q2 | $144K | Hold |
156,850
| – | – | 0.04% | 143 |
|
|
2022
Q1 | $281K | Buy |
+156,850
| New | +$281K | 0.06% | 127 |
|
|
2021
Q3 | $318K | Hold |
156,850
| – | – | 0.07% | 128 |
|
|
2021
Q2 | $546K | Buy |
156,850
+50,000
| +47% | +$174K | 0.13% | 103 |
|
|
2021
Q1 | $0 | Buy |
106,850
+1,000
| +0.9% | – | ﹤0.01% | 144 |
|
|
2020
Q4 | $107K | Buy |
+105,850
| New | +$107K | 0.03% | 158 |
|